MedPath

Mobile Technology to Assist Patient Education and Research in Arthroplasty

Not Applicable
Recruiting
Conditions
Total Knee Replacement
Total Hip Replacement
Musculoskeletal - Osteoarthritis
Musculoskeletal - Other muscular and skeletal disorders
Surgery - Other surgery
Registration Number
ACTRN12620001067965
Lead Sponsor
Medacta Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients 18 years or over presenting with hip or knee arthritis that meets the indications for hip or knee arthroplasty respectively
- Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery
- Patients who are considered by the surgeon to be capable of following the patient optimised pathway

Exclusion Criteria

- Patients under the age of 18 years
- Patients with one or more medical conditions identified as a contraindication defined by the labelling on any Medacta implants used in this study
- Any patient who cannot or will not provide informed consent for participation in the study
- Patients who need revision surgery
- Patients unable to communicate in English
- Any case not described in the inclusion criteria
- Patients who do not own a compatible smartphone

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient satisfaction with the mobile phone application (app) in delivering information on their treatment program, rehabilitation and research tools.<br>This is assessed by patient completion of study-specific patient satisfaction survey delivered via the app.[Baseline (pre-surgery), Day 1, 2 weeks, 6 weeks, 3 months and 6 months post-surgery.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath